Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Molecular Analysis for Precision Oncology Congress 2024

ESMO-MAP-2024-1000x250-Molecular-Analysis

Start date: 16 Oct 2024
End date: 18 Oct 2024
Location: London, United Kingdom

The Molecular Analysis for Precision Oncology Congress 2024 took place from 16 to 18 October 2024 in London, UK.

MAP focused on current and emerging approaches in precision oncology, highlighted successes and challenges, and proposed potential solutions in clinical research and practice.

Our globally recognised experts in the field attracted attendees for three days of discussions on discoveries in precision medicine, technologies for cancer profiling, mechanisms driving tumour expansion, metastatic dissemination, clonal evolution, and biomarker-driven development of targeted therapeutics.

The 2024 RoadMAP to the Clinic focused on “The use of AI for drug development / precision medicine.” This special day featured lectures and panel discussions involving investigators, regulatory and methodological experts, industry and patient representatives on the burning topics of deploying AI at scale, tackling regulatory and ethical aspects of AI implementation in clinical trials, and examining the opportunities and challenges of AI for research and practice.

The MAP Congress is the result of a solid partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO), and Unicancer, all committed to offering the best care to people with cancer worldwide through oncology education and research.